ROMILKIMAB
UNII O8HNJ174XS

Substance Identification & Data

This profile provides standardized clinical and technical data for Romilkimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) O8HNJ174XS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1399584-78-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

O8HNJ174XS

CAS Registry Number

1399584-78-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ROMILKIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C174791

National Cancer Institute reference terminology for clinical and research data.

INN ID

10622

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

FG-222

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Romilkimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ROMILKIMAB

Common Names & Synonyms

HUTBTI3_2_1

IMMUNOGLOBULIN G4, BISPECIFIC, ANTI-(HUMAN INTERLEUKIN 4/INTERLEUKIN 13)(HUMANIZED CLONES HU8D4-8-AND HUBB13-CONTG. .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED CLONES HU8D4-8-AND HUBB13-CONTG. .KAPPA.-CHAIN, DIMER

ROMILKIMAB [INN]

ROMILKIMAB [USAN]

ROMILKIMAB [WHO-DD]